29 September 2023 in British Journal of Nutrition
Systolic blood pressure (SBP) is significantly associated with body composition in children and adolescents. However, which one of the components of body composition is the dominant contributor to SBP in children and adolescents remains unclear. We, therefore, aimed to determine the dominant contributor to SBP among components of body composition in a large cohort of American children and adolescents derived from the National Health and Nutrition Examination Survey with cross-sectional analysis. In total, 13 618 children and adolescents (median age 13 years; 6107 girls) with available data on whole-body dual-emission X-ray absorptiometry measurements were included. Multiple linear regression showed that SBP was associated with higher total fat-free mass in boys (β = 0·49, P < 0·001) and girls (β = 0·47, P < 0·001) and with higher total fat mass only in boys (β = 0·12, P < 0·001) after adjustment for covariates. When taking fat distribution into consideration, SBP was associated with higher trunk fat mass (boys: β = 0·28, P < 0·001; girls: β = 0·15, P < 0·001) but negatively associated with leg fat mass (Boys: β = −0·14, P < 0·001; Girls: β = −0·11, P < 0·001), in both boys and girls. Dominance analysis showed that total fat-free mass was the dominant contributor to SBP (boys: 49 %; girls: 55·3 %), followed by trunk fat mass (boys: 32·1 %; girls: 26·9 %); leg fat mass contributed the least to SBP in boys (18·9 %) and girls (17·8 %). Our findings indicated that total fat-free mass was not only associated with SBP but also the most dominant contributor to SBP variation in American children and adolescents.
21 March 2024 in Nature Aging
6 January 2026 in Journal of the American Heart Association
NSNorthern Shanghai Study
+4
Background: The subendocardial viability ratio (SEVR) reflects myocardial perfusion relative to workload. This study explored the association of SEVR with mortality and subclinical target organ damage in an older adult population. Methods: We analyzed the data from the Northern Shanghai Study, a community‐based cohort of older adults aged over 65 years. SEVR was measured with arterial tonometry. Cross‐sectional associations were assessed between SEVR levels and target organ damage (including arterial stiffness, peripheral artery disease, carotid plaque, left ventricular hypertrophy, left ventricular diastolic dysfunction, chronic kidney dysfunction, and microalbuminuria). Longitudinal associations between SEVR and mortality were evaluated using Cox and Fine‐Gray models. Results: Among 3237 participants (mean age 71±6 years, 57% female), 233 deaths occurred over a median follow‐up of 5.7 years, including 94 cardiovascular deaths. Participants were divided into 2 groups by the median value of SEVR (129%). The group with a lower SEVR (≤129%) was associated with higher risk of cardiovascular death (adjusted Cox Hazard Ratio [HR]=1.70 [1.05–2.75]; P =0.03), but not with all‐cause death (adjusted Cox HR=1.30 [0.98–1.73]; P =0.07). As for target organ damage, participants with more damaged organs had lower SEVR values ( P for trend <0.001). Specifically, the occurrence of arterial stiffness and left ventricular diastolic dysfunction increased the potential of worse SEVR, with odds ratio 1.46 (1.17–1.83); P <0.001, and 1.90 (1.35–2.67); P <0.001, respectively. Conclusions: Lower SEVR is independently associated with both increased cardiovascular mortality and organ damage, including arterial stiffness and left ventricular diastolic dysfunction in older adult populations. SEVR may be a convenient marker for early cardiovascular risk stratification in aging populations. Registration: URL: https://ClinicalTrial.gov ; Unique Identifier: NCT02368938.
1 November 2026 in Hypertension
BACKGROUND: To directly compare the predictive ability of carotid-femoral pulse wave velocity (cf-PWV) and brachial-ankle pulse wave velocity (ba-PWV) for cardiovascular events within the same population. METHODS: This is a community-based prospective cohort study that included older adults (>65 years). The primary end point was major adverse cardiovascular events (MACEs), including cardiovascular mortality, nonfatal myocardial infarction, and nonfatal stroke. RESULTS: A total of 3309 participants (median age [quartiles], 70 [67–75] years; 1434 [43.3%] men) were included. The median follow-up time was 6.40 [6.37–6.41] years. Cf-PWV and ba-PWV were moderately correlated ( R =0.588; P <0.001). Participants were divided into 4 groups by quartiles or 2 groups using cutoff values. Aalen-Johansen estimators and Cox regression analyses indicated that both cf-PWV and ba-PWV were associated with an increased rate of MACEs. When cf-PWV and ba-PWV were cross-adjusted, only cf-PWV remained significantly associated with MACEs and mortality (hazard ratio, 1.12 [95% CI, 1.00–1.25]; P =0.048 and 1.16 [95% CI, 1.03–1.29]; P =0.032, respectively) in both full-model and stepwise regressions. Stratification based on cf-PWV and ba-PWV cutoff values further revealed that elevated cf-PWV was associated with a higher risk of MACEs, independent of baseline ba-PWV. Concordance index, net reclassification improvement, and integrated discrimination improvement analyses confirmed the additive value of cf-PWV to conventional cardiovascular risk factors. Other stiffness-related parameters, including pulse pressure and its amplification, were not independently associated with MACEs. CONCLUSIONS: Both cf-PWV and ba-PWV are associated with cardiovascular events, and cf-PWV demonstrates a higher predictive value compared with ba-PWV. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02368938.